Mahtab Farzin

827 total citations
22 papers, 441 citations indexed

About

Mahtab Farzin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Mahtab Farzin has authored 22 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Mahtab Farzin's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers) and Cancer Genomics and Diagnostics (5 papers). Mahtab Farzin is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers) and Cancer Genomics and Diagnostics (5 papers). Mahtab Farzin collaborates with scholars based in Australia. Mahtab Farzin's co-authors include Anthony J. Gill, Loretta Sioson, Christopher W. Toon, Adele Clarkson, Nicole Watson, Juliana Andrici, Amy Sheen, Angela Chou, Christina Selinger and Mahsa Ahadi and has published in prestigious journals such as PLoS ONE, The American Journal of Surgical Pathology and Human Pathology.

In The Last Decade

Mahtab Farzin

20 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mahtab Farzin Australia 10 271 132 86 81 60 22 441
Audrey Gros France 11 188 0.7× 233 1.8× 80 0.9× 142 1.8× 84 1.4× 26 449
Gillianne Lai Singapore 5 197 0.7× 190 1.4× 122 1.4× 70 0.9× 60 1.0× 18 374
Sotaro Otake Japan 12 140 0.5× 104 0.8× 61 0.7× 60 0.7× 91 1.5× 17 354
Bisong Haupt United States 11 85 0.3× 201 1.5× 69 0.8× 91 1.1× 32 0.5× 11 386
Eduardo Caetano Albino da Silva Brazil 11 122 0.5× 123 0.9× 140 1.6× 35 0.4× 30 0.5× 28 350
Melanie Schrumpf Netherlands 7 112 0.4× 137 1.0× 84 1.0× 117 1.4× 28 0.5× 8 308
J. Morreau Netherlands 5 87 0.3× 194 1.5× 47 0.5× 53 0.7× 40 0.7× 7 296
Byeong‐Joo Noh South Korea 11 106 0.4× 101 0.8× 86 1.0× 28 0.3× 54 0.9× 30 327
Yanfen Feng China 14 88 0.3× 201 1.5× 130 1.5× 109 1.3× 26 0.4× 39 429
Emma Spurrell United Kingdom 7 184 0.7× 144 1.1× 63 0.7× 34 0.4× 17 0.3× 11 307

Countries citing papers authored by Mahtab Farzin

Since Specialization
Citations

This map shows the geographic impact of Mahtab Farzin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahtab Farzin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahtab Farzin more than expected).

Fields of papers citing papers by Mahtab Farzin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahtab Farzin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahtab Farzin. The network helps show where Mahtab Farzin may publish in the future.

Co-authorship network of co-authors of Mahtab Farzin

This figure shows the co-authorship network connecting the top 25 collaborators of Mahtab Farzin. A scholar is included among the top collaborators of Mahtab Farzin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahtab Farzin. Mahtab Farzin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Farzin, Mahtab, Victoria Bray, Jonathan Williamson, et al.. (2024). The histopathological spectrum and molecular changes associated with KRAS G12C mutation in non-small cell lung carcinoma. Pathology. 56(6). 786–794. 1 indexed citations
3.
Pal, Abhijit, Stephanie Lim, Kate Wilkinson, et al.. (2023). Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian population. PLoS ONE. 18(10). e0292087–e0292087. 1 indexed citations
4.
Farzin, Mahtab, Andrew Gilmore, Harry Crane, et al.. (2023). Colonic Epstein-Barr Virus-Associated Mucocutaneous Ulcer Associated With Ulcerative Colitis. ACG Case Reports Journal. 10(2). e00978–e00978. 2 indexed citations
5.
Pal, Abhijit, Victoria Bray, Po Yee Yip, et al.. (2023). Utility of multigene panel next‐generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer. Internal Medicine Journal. 54(4). 596–601. 3 indexed citations
6.
Sharma, Raghwa, et al.. (2019). Malignant basomelanocytic tumour: a case report. Pathology. 51. S99–S100. 1 indexed citations
7.
Sharma, Raghwa, et al.. (2018). Acknowledging uterine angiolipoleiomyoma as a new diagnostic term: A proposal. Pathology. 50. S75–S75. 2 indexed citations
8.
Andrici, Juliana, Mahtab Farzin, Loretta Sioson, et al.. (2016). Mismatch repair deficiency as a prognostic factor in mucinous colorectal cancer. Modern Pathology. 29(3). 266–274. 40 indexed citations
9.
Wang, Jennifer, Juliana Andrici, Loretta Sioson, et al.. (2016). Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency. Human Pathology. 55. 83–90. 19 indexed citations
10.
Andrici, Juliana, Mahtab Farzin, Adele Clarkson, et al.. (2016). Mutation specific immunohistochemistry is highly specific for the presence of calreticulin mutations in myeloproliferative neoplasms. Pathology. 48(4). 319–324. 13 indexed citations
11.
Andrici, Juliana, Jason Jung, Arjun Singh, et al.. (2016). Loss of expression of BAP1 is very rare in non-small cell lung carcinoma. Pathology. 48(4). 336–340. 30 indexed citations
12.
Andrici, Juliana, Mahtab Farzin, Adele Clarkson, et al.. (2016). Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma. PLoS ONE. 11(3). e0150338–e0150338. 10 indexed citations
13.
Andrici, Juliana, Amy Sheen, Loretta Sioson, et al.. (2015). Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology. Modern Pathology. 28(10). 1360–1368. 74 indexed citations
14.
Farzin, Mahtab, Christopher W. Toon, Adele Clarkson, et al.. (2015). Loss of expression of BAP1 predicts longer survival in mesothelioma. Pathology. 47(4). 302–307. 88 indexed citations
15.
Chou, Angela, Sheila Fraser, Christopher W. Toon, et al.. (2014). A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma. The American Journal of Surgical Pathology. 39(5). 652–659. 77 indexed citations
16.
Toon, Christopher W., Adele Clarkson, Loretta Sioson, et al.. (2014). Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer. Pathology. 46(5). 383–388. 29 indexed citations
17.
Sioson, Loretta, Adele Clarkson, Nicole Watson, et al.. (2014). EGFR mutation specific immunohistochemistry is a useful adjunct which helps to identify false negative mutation testing in lung cancer. Pathology. 46(6). 501–508. 9 indexed citations
18.
19.
Farzin, Mahtab, Christopher W. Toon, Adele Clarkson, Loretta Sioson, & Anthony J. Gill. (2013). BRAF V600E mutation specific immunohistochemistry with clone VE1 is not reliable in pituitary adenomas. Pathology. 46(1). 79–80. 5 indexed citations
20.
Farzin, Mahtab, et al.. (2012). An analysis of IMP3 expression in lung cancer. Pathology. 44. S72–S73.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Audrey Gros Breakdown of academic impact, for papers by Gillianne Lai Breakdown of academic impact, for papers by Sotaro Otake Breakdown of academic impact, for papers by Bisong Haupt Breakdown of academic impact, for papers by Eduardo Caetano Albino da Silva Breakdown of academic impact, for papers by Melanie Schrumpf Breakdown of academic impact, for papers by J. Morreau Breakdown of academic impact, for papers by Byeong‐Joo Noh Breakdown of academic impact, for papers by Yanfen Feng Breakdown of academic impact, for papers by Emma Spurrell
Rankless by CCL
2026